Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for ARN-810

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBREP12116

    03/25/2013

    An Open-Label, Phase IA/IB/IIA Study of GDC-810 Single Agent or in Combination With Palbociclib and/or an LHRH Agonist in Women with Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer


    Print this page for your doctor